I 
119TH CONGRESS 
1ST SESSION H. R. 1806 
To provide for research and education with respect to triple-negative breast 
cancer, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
MARCH 3, 2025 
Mr. MORELLE (for himself and Mr. BACON) introduced the following bill; 
which was referred to the Committee on Energy and Commerce 
A BILL 
To provide for research and education with respect to triple- 
negative breast cancer, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Triple-Negative Breast 
Cancer Research and Education Act of 2025’’. 
SEC. 2. FINDINGS. 
Congress finds as follows: 
(1) Breast cancer accounts for 1 in 4 cancer di-
agnoses among women in this country. 
VerDate Sep 11 2014 
00:50 Mar 18, 2025
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H1806.IH
H1806
ssavage on LAPJG3WLY3PROD with BILLS
(2) The survival rate for breast cancer has in-
creased to 90 percent for White women and 78 per-
cent for African-American women. 
(3) African-American women are more likely to 
be diagnosed with larger tumors and more advanced 
stages of breast cancer despite a lower incidence 
rate. 
(4) Early detection for breast cancer increases 
survival rates for breast cancer, as evidenced by a 5- 
year relative survival rate of 98 percent for breast 
cancers that are discovered before the cancer 
spreads beyond the breast, compared to 23 percent 
for stage IV breast cancers. 
(5) Triple-negative breast cancer is a term used 
to describe breast cancers whose cells do not have 
estrogen receptors and progesterone receptors, and 
do not have an excess of the HER2 protein on their 
sources. 
(6) It is estimated that between 10 and 20 per-
cent of female breast cancer patients are diagnosed 
with triple-negative breast cancer, and studies indi-
cate the prevalence of triple-negative breast cancer is 
much higher. 
VerDate Sep 11 2014 
00:50 Mar 18, 2025
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H1806.IH
H1806
ssavage on LAPJG3WLY3PROD with BILLS
(7) Triple-negative breast cancer most com-
monly affects African-American women, followed by 
Hispanic women. 
(8) Triple-negative breast cancer is a very ag-
gressive form of cancer which affects women under 
the age of 50 across all racial and socioeconomic 
backgrounds. 
(9) African-American women are 3 times more 
likely to develop triple-negative breast cancer than 
White women. 
(10) Triple-negative breast cancer tends to 
grow and spread more quickly than most other types 
of breast cancer. 
(11) Like other forms of breast cancer, triple- 
negative breast cancer is treated with surgery, radi-
ation therapy, or chemotherapy. 
(12) Early-stage detection of triple-negative 
breast cancer is the key to survival because the 
tumor cells lack certain receptors, and neither hor-
mone therapy nor drugs that target these receptors 
are effective against these cancers; therefore, early 
detection and education is vital. 
(13) Current research and available data do not 
provide adequate information on— 
VerDate Sep 11 2014 
00:50 Mar 18, 2025
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H1806.IH
H1806
ssavage on LAPJG3WLY3PROD with BILLS
(A) the rates of prevalence and incidence 
of triple-negative breast cancer in African- 
American, Hispanic, and other minority women; 
(B) the costs associated with treating tri-
ple-negative breast cancer; and 
(C) the methods by which triple-negative 
breast cancer may be prevented or cured in 
these women. 
SEC. 3. TRIPLE-NEGATIVE BREAST CANCER. 
Subpart I of part C of title IV of the Public Health 
Service Act (42 U.S.C. 285 et seq.) is amended by insert-
ing after section 417A (42 U.S.C. 285a–7) the following: 
‘‘SEC. 417B. TRIPLE-NEGATIVE BREAST CANCER. 
‘‘(a) RESEARCH.— 
‘‘(1) IN GENERAL.—The Director of the Na-
tional Institutes of Health (in this section referred 
to as the ‘Director of NIH’) shall expand, intensify, 
and coordinate programs for the conduct and sup-
port of research with respect to triple-negative 
breast cancer. 
‘‘(2) ADMINISTRATION.—The Director of NIH 
shall carry out this subsection through the appro-
priate institutes, offices, and centers of the National 
Institutes of Health, including the Eunice Kennedy 
Shriver National Institute of Child Health and 
VerDate Sep 11 2014 
00:50 Mar 18, 2025
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H1806.IH
H1806
ssavage on LAPJG3WLY3PROD with BILLS
Human Development, the National Institute of En-
vironmental Health Sciences, the Office of Research 
on Women’s Health, and the National Institute on 
Minority Health and Health Disparities. 
‘‘(3) COORDINATION OF ACTIVITIES.—The Di-
rector of the Office of Research on Women’s Health 
shall coordinate activities under this subsection 
among the institutes, offices, and centers of the Na-
tional Institutes of Health. 
‘‘(4) AUTHORIZATION
OF
APPROPRIATIONS.— 
For the purposes of carrying out this subsection, 
there are authorized to be appropriated such sums 
as may be necessary for each of the fiscal years 
2026 through 2031. 
‘‘(b) EDUCATION AND DISSEMINATION OF INFORMA-
TION WITH RESPECT
TO TRIPLE-NEGATIVE BREAST 
CANCER.— 
‘‘(1) TRIPLE-NEGATIVE BREAST CANCER PUB-
LIC
EDUCATION
PROGRAM.—The 
Secretary 
of 
Health and Human Services, acting through the Di-
rector of the Centers for Disease Control and Pre-
vention, shall develop and disseminate to the public 
information regarding triple-negative breast cancer, 
including information on— 
VerDate Sep 11 2014 
00:50 Mar 18, 2025
Jkt 059200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H1806.IH
H1806
ssavage on LAPJG3WLY3PROD with BILLS
‘‘(A) the incidence and prevalence of triple- 
negative breast cancer among women; 
‘‘(B) the elevated risk for minority women 
to develop triple-negative breast cancer; and 
‘‘(C) the availability, as medically appro-
priate, of a range of treatment options for 
symptomatic triple-negative breast cancer. 
‘‘(2) DISSEMINATION
OF
INFORMATION.—The 
Secretary may disseminate information under para-
graph (1) directly or through arrangements with 
nonprofit organizations, consumer groups, institu-
tions of higher education, Federal, State, or local 
agencies, or the media. 
‘‘(3) AUTHORIZATION
OF
APPROPRIATIONS.— 
For the purpose of carrying out this subsection, 
there are authorized to be appropriated such sums 
as may be necessary for each of the fiscal years 
2026 through 2031. 
‘‘(c) INFORMATION TO HEALTH CARE PROVIDERS 
WITH RESPECT
TO TRIPLE-NEGATIVE BREAST CAN-
CER.— 
‘‘(1) DISSEMINATION
OF
INFORMATION.—The 
Secretary of Health and Human Services, acting 
through the Administrator of the Health Resources 
and Services Administration, shall develop and dis-
VerDate Sep 11 2014 
00:50 Mar 18, 2025
Jkt 059200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H1806.IH
H1806
ssavage on LAPJG3WLY3PROD with BILLS
seminate to health care providers information on tri-
ple-negative breast cancer for the purpose of ensur-
ing that health care providers remain informed 
about current information on triple-negative breast 
cancer. Such information shall include the elevated 
risk for minority women to develop triple-negative 
breast cancer and the range of available options for 
the treatment of symptomatic triple-negative breast 
cancer. 
‘‘(2) AUTHORIZATION
OF
APPROPRIATIONS.— 
For the purpose of carrying out this subsection, 
there are authorized to be appropriated such sums 
as may be necessary for each of the fiscal years 
2026 through 2031. 
‘‘(d) DEFINITION.—In this section, the term ‘minor-
ity women’ means women who are members of a racial 
and ethnic minority group, as defined in section 
1707(g).’’. 
Æ 
VerDate Sep 11 2014 
00:50 Mar 18, 2025
Jkt 059200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6301
E:\BILLS\H1806.IH
H1806
ssavage on LAPJG3WLY3PROD with BILLS